Phase Forward to Host Seventh Annual European Users Conference

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will host its seventh annual European Users Conference (EUC) on Thursday, May 14 at the Radisson SAS Hotel in London, England. The conference will offer a full day of industry, product and customer-led sessions.

Company Chairman and CEO, Bob Weiler, and Senior Vice President of Worldwide Sales, Steve Powell, will commence the day with a welcoming keynote address. Immediately following, Raveh Gill-More, Vice President of BrainsGate, Ltd. and Akiko Oguma of Fujitsu’s Life Sciences Systems Division, Health Care Unit, will deliver the customer keynote addresses.

The conference will also feature 12 customer-driven sessions across two eClinical- and safety-focused tracks, including presentations by Novo Nordisk, Aptuit, Sanofi Pasteur, Quintiles and AstraZeneca. Additionally, Phase Forward Vice Presidents Jagath Wanninayake and Himanshu Oberoi will lead in-depth product sessions on the company’s Clarix and Waban Product Groups, respectively.

“As the pharmaceutical industry remains steadfast in its commitment to leveraging technological innovation for the advancement of drug discovery and development, we too remain committed to this end – and to delivering the premier tools and services our customers require to succeed,” said Weiler. “We applaud their results to date and their fierce dedication to expanding product efficacy and drug safety worldwide.”

To view the full agenda and to register, please click here.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica Signal™) and Signal Management, adverse event reporting (Empirica Trace™), applied data standards (WebSDM™), Web-integrated interactive response technologies (Clarix™), and clinical data analysis and reporting automation and compliance (Waban SCE/CDR, Waban SMS and Waban LIMS). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.